Biology Reference
In-Depth Information
Fukasawa K (2005) Centrosome amplification, chromosome instability and cancer development.
Cancer Lett 230:6-19
Fukasawa K (2007) Oncogenes and tumour suppressors take on centrosomes. Nat Rev Cancer
7:911-924
Fukasawa K (2011) Aberrant activation of cell cycle regulators, centrosome amplification, and
mitotic defects. Horm Cancer 2:104-112
Furihata M, Ohtsuki Y, Sonobe H, Shuin T, Yamamoto A, Terao N, Kuwahara M (1998)
Prognostic significance of cyclin E and p53 protein overexpression in carcinoma of the renal
pelvis and ureter. Br J Cancer 77:783-788
Grisendi S, Bernardi R, Rossi M, Cheng K, Khandker L, Manova K, Pandolfi PP (2005) Role of
Nucleophosmin in embryonic development and tumorigenesis. Nature 437:147-153
Hanashiro K, Kanai M, Geng Y, Sicinski P, Fukasawa K (2008) Roles of cyclins A and E in
induction of centrosome amplification in p53-compromised cells. Oncogene 27:5288-5302
Hanashiro K, Brancaccio M, Fukasawa K (2011) Activated ROCK II by-passes the requirement
of the CDK2 activity for centrosome duplication and amplification. Oncogene 30:2188-2197
Haupt Y, Kazaz A, Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature
387:296-299
Hinchcliffe EH, Li C, Thompson EA, Maller JL, Sluder G (1999) Requirement of Cdk2-cyclin E
activity for repeated centrosome reproduction in Xenopus egg extracts. Science 283:851-854
Hung LY, Tseng JT, Lee YC, Xia W, Wang YN, Wu ML, Chuang YH, Lai CH, Chang WC
(2008) Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and
activator of transcription 5 (STAT5) in activating Aurora-A gene expression. Nucleic Acids
Res 36:4337-4351
Kanai M, Crowe MS, Zheng Y, Vande Woude GF, Fukasawa K (2010) RhoA and RhoC are both
required for the ROCK II-dependent promotion of centrosome duplication. Oncogene 29:6040-6050
Karakaidos P, Taraviras S, Vassiliou LV, Zacharatos P, Kastrinakis NG, Kougiou D,
Kouloukoussa M, Nishitani H, Papavassiliou AG, Lygerou Z, Gorgoulis VG, Karakaidos P,
Taraviras S, Vassiliou LV, Zacharatos P, Kastrinakis NG, Kougiou D, Kouloukoussa M,
Nishitani H, Papavassiliou AG, Lygerou Z, Gorgoulis VG (2004) Overexpression of the
replication licensing regulators hCdt1 and hCdc6 characterizes a subset of non-small-cell lung
carcinomas: synergistic effect with mutant p53 on tumor growth and chromosomal instability-
evidence of E2F-1 transcriptional control over hCdt1. Am J Pathol 165:1351-1365
Kawamura K, Izumi H, Ma Z, Ikeda R, Moriyama M, Tanaka T, Nojima T, Levin LS, Fujikawa-
Yamamoto K, Suzuki K, Fukasawa K (2004) Induction of centrosome amplification and
chromosome instability in human bladder cancer cells by p53 mutation and cyclin E
overexpression. Cancer Res 64:4800-4809
Keyomarsi K, Herliczek TW (1997) The role of cyclin E in cell proliferation, development and
cancer. Prog Cell Cycle Res 3:171-191
Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan DO,
Franza BR, Roberts JM (1992) Formation and activation of a cyclin E-cdk2 complex during
the G1 phase of the human cell cycle. Science 257:1689-1694
Kubbutat MH, Jones SN, Vousden K (1997) Regulation of p53 stability by Mdm2. Nature
387:299-303
Lacey KR, Jackson PK, Stearns T (1999) Cyclin-dependent kinase control of centrosome
duplication. Proc Natl Acad Sci U S A 96:2817-2822
Leung T, Chen XQ, Manser E, Lim L (1996) The p160 RhoA-binding kinase ROK alpha is a
member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol Cell
Biol 16:5313-5327
Matsui T, Amano M, Yamamoto T, Chihara K, Nakafuku M, Ito M, Nakano T, Okawa K,
Iwamatsu A, Kaibuchi K (1996) Rho-associated kinase, a novel serine/threonine kinase, as a
putative target for small GTP binding protein Rho. EMBO J 15:2208-2216
Ma Z, Kanai M, Kawamura K, Kaibuchi K, Ye K, Fukasawa K (2006) Interaction between
ROCK II and nucleophosmin/B23 in the regulation of centrosome duplication. Mol Cell Biol
26:9016-9034
Search WWH ::




Custom Search